Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Marlboro cigarette maker Altria Group Inc. (NYSE: MO) has been a dependable source of high dividends for years.

Do Cheap Cigarettes Really Threaten Altria Stock?

Increased global pressure causes leading e-cig maker to further restrict its exposure.

E-Cig Maker Juul Reportedly Exiting 5 European Markets

Altria: Don't Be Surprised

Despite an 18% decline in Altria’s stock since the beginning of this year as the spread of the novel Coronavirus rattled the stock markets and the broader economy, at the current price of $40 per share, we believe Altria has a significant downside if there are no signs of abatement.

Could Altria’s Stock Drop To 8-Year Low Of Below $30?

Altria Group, Inc. (MO) CEO Billy Gifford on Q1 2020 Results - Earnings Call Transcript

But customers began trading down to cheaper brands to make their purchases go further.

Altria Shows Sales Surge as Smokers Stocked Up on Cigarettes for COVID-19 Pandemic

Altria's (MO) first-quarter 2020 results reflect growth in oral tobacco products and smokeable segments. Management withdraws 2020 earnings guidance due to coronavirus.

Altria's (MO) Q1 Earnings Top Estimates, Guidance Withdrawn

Altria (MO) delivered earnings and revenue surprises of 12.37% and 9.23%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Altria (MO) Tops Q1 Earnings and Revenue Estimates

Shares of Altria Group Inc. MO, -0.59% jumped 2.6% in premarket trading, after the cigarette seller beat profit and revenue expectations, as COVID-19-related pantry loading helped boost shipment volumes.

Altria's stock rallies after profit and revenue beats, as COVID-19-related pantry loading boosts cigarette shipments

The restructuring is aimed at reducing costs as legal challlenges mount.

Juul Labs Is Looking to Cut a Third of Its Employees

Altria Group (MO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Altria Group (MO) Might Surprise This Earnings Season

Altria Group Inc. (NYSE: MO) has carved out a niche in the United States as one of the biggest producers of cigarettes and smokeless tobacco products.

Altria Stock’s Attractive Value Proposition Going Into Earnings

Altria's (MO) first-quarter 2020 performance is likely to reflect gains from pricing and strength in Smokeless products.

Here's What You Must Note Ahead of Altria's (MO) Q1 Earnings

Tanger Factory Outlet Centers

AT&T

A tobacco giant, factory outlet mall operator, and telco icon are among three high-yielding stocks that offer capital appreciation upside on their out-of-favor stocks.

3 Hated Dividend Stocks to Buy Now: MO, SKT & T

Brookfield Infrastructure Partners L.P.

Clorox

Costco

Gilead Sciences

Innovative Industrial Properties

Johnson & Johnson

Microsoft

Target

Verizon

If you're in search of yield in the stock market, these outstanding businesses could make for excellent investments.

The 10 Best Dividend Stocks for 2020

The tobacco giant counters that the regulatory agency is misunderstanding the facts of its e-cig investment.

FTC Looks to Unwind Altria's $12.8 Billion JUUL Investment

British American Tobacco

Philip Morris

The plaintiff says the heat-not-burn technology violated patents it's owned for years.

British American Tobacco Sues Altria and Philip Morris over IQOS

Imperial Brands PLC

Nielsen Hlds

Overall shipment volumes could continue growing as smokers have more time and opportunity to smoke.

Cigarette Sales Tumble After Initial Pandemic Panic Buying

The tobacco giant announced a new leader after its previous CEO took a COVID-19-related medical leave. The shares hit a seven-year low last month, but there's a smoking-hot opportunity here, too.

Will a New CEO Save Altria Stock?

He's retiring after recovering from COVID-19.

Altria CEO Howard Willard Steps Down

Altria Group Inc. MO, -1.24% said Chairman and Chief Executive Howard Willard, who was recovering from COVID-19, is stepping down after 28 years with the company.

Altria CEO Howard Willard retires, was recovering from COVID-19

AbbVie

Automatic Data Processing

Emerson Electric

Federal Realty Investment Trust

General Dynamics

Lowe's

Medtronic

Parker-Hannifin

Raytheon Technologies

Stanley Black & Decker

T. Rowe Price Group

Last week the S&P 500 had its best week since 1974, roaring higher by 12%. That defies the mounting economic damage the US is facing and plummeting earnings expectations.

The 13 Best Dividend Aristocrats To Buy In This Uncertain Economy

This won't be the first time these companies have fought in court over intellectual property related to e-cigarettes.

British American Tobacco Sues Altria and Philip Morris for E-Cigarette Patent Infringement

Altria: Ignore The JUUL Drama, The Political Markets Are Improving

BTI vs. MO: Which Stock Is the Better Value Option?

News for Altria Stock (MO)